New biomarkers allow for better diagnosis in MS
Posted: Tue May 31, 2011 5:13 am
Biomarkers – mainly defined as surrogates serving as indicators for specific biological states – play an ever-increasing role in neuroscience and especially in the management of multiple sclerosis, scientists reported today at the 21st Meeting of the European Neurological Society (ENS) in Lisbon.
In analyzing gene expression patterns, immunological changes and imaging abnormalities, physicians are now able to detect complex nervous diseases at an early stage, to better discern them from other types with similar clinical manifestations, to better foresee the outcome and to evaluate whether or not a patient responds adequately to a specific therapy.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1863